第一单位：
Department of Medical Oncology, University Hospital of Besançon, Besançon, France.;INSERM, EFS BFC, UMR1098, RIGHT, University of Bourgogne Franche-Comté, Besançon, France.
作者：
Olivier,Adotévi [1]
;
Dewi,Vernerey [2]
;
Pascale,Jacoulet [3]
;
Aurélia,Meurisse [4]
;
Caroline,Laheurte [5]
;
Hamadi,Almotlak [6]
;
Marion,Jacquin [7]
;
Vincent,Kaulek [3]
;
Laura,Boullerot [8]
;
Marine,Malfroy [9]
;
Emeline,Orillard [10]
;
Guillaume,Eberst [11]
;
Aurélie,Lagrange [12]
;
Laure,Favier [12]
;
Marie,Gainet-Brun [3]
;
Ludovic,Doucet [13]
;
Luis,Teixeira [13]
;
Zineb,Ghrieb [14]
;
Anne-Laure,Clairet [15]
;
Yves,Guillaume [15]
;
Marie,Kroemer [15]
;
Didier,Hocquet [16]
;
Mélanie,Moltenis [17]
;
Samuel,Limat [18]
;
Elisabeth,Quoix [19]
;
Céline,Mascaux [20]
;
Didier,Debieuvre [21]
;
Christine,Fagnoni-Legat [15]
;
Christophe,Borg [22]
;
Virginie,Westeel [11]
作者单位：
Department of Medical Oncology, University Hospital of Besançon, Besançon, France.;INSERM, EFS BFC, UMR1098, RIGHT, University of Bourgogne Franche-Comté, Besançon, France.
[1]
INSERM, EFS BFC, UMR1098, RIGHT, University of Bourgogne Franche-Comté, Besançon, France.;Department of Medical Oncology, Methodology and Quality of Life Unit in Oncology, University Hospital of Besançon, Besançon, France.
[2]
Department of Pneumology, University Hospital of Besançon, Besançon, France.
[3]
Department of Medical Oncology, Methodology and Quality of Life Unit in Oncology, University Hospital of Besançon, Besançon, France.
[4]
INSERM, EFS BFC, UMR1098, RIGHT, University of Bourgogne Franche-Comté, Besançon, France.;EFS Bourgogne Franche-Comté, UMR1098, Plateforme de Biomonitoring, Besançon, France.
[5]
Department of Medical Oncology, University Hospital of Besançon, Besançon, France.
[6]
INSERM CIC-1431, Clinical Investigation Center in Biotherapy, University Hospital of Besançon, Besançon, France.
[7]
INSERM, EFS BFC, UMR1098, RIGHT, University of Bourgogne Franche-Comté, Besançon, France.;EFS Bourgogne Franche-Comté, UMR1098, Plateforme de Biomonitoring, Besançon, France.;INSERM CIC-1431, Clinical Investigation Center in Biotherapy, University Hospital of Besançon, Besançon, France.
[8]
INSERM, EFS BFC, UMR1098, RIGHT, University of Bourgogne Franche-Comté, Besançon, France.
[9]
Department of Medical Oncology, University Hospital of Besançon, Besançon, France.;Department of Pneumology, University Hospital of Besançon, Besançon, France.
[10]
INSERM, EFS BFC, UMR1098, RIGHT, University of Bourgogne Franche-Comté, Besançon, France.;Department of Pneumology, University Hospital of Besançon, Besançon, France.
[11]
Department of Medical Oncology, Georges François Leclerc Cancer Center-UNICANCER, Dijon, France.
[12]
Department of Medical Oncology, AP-HP Hôpital Saint Louis, Paris, France.
[13]
INSERM CIC 1427, Centre d'Investigations Cliniques, Université de Paris Cité, AP-HP Hôpital Saint-Louis, Paris, France.
[14]
Department of Pharmacy, University Hospital of Besançon, Besançon, France.
[15]
Hygiène Hospitalière, Centre Hospitalier Universitaire, Besançon, France.
[16]
Vigilance Unit, Department of Clinical Research and Innovation, University Hospital of Besançon, Besançon, France.
[17]
INSERM, EFS BFC, UMR1098, RIGHT, University of Bourgogne Franche-Comté, Besançon, France.;Department of Pharmacy, University Hospital of Besançon, Besançon, France.
[18]
Department of Pneumology, Strasbourg University Hospital, Strasbourg, France.
[19]
University of Strasbourg, Inserm UMR_S1113, IRFAC, Laboratory Streinth (Stress rEsponse and iNnovative therapy against cancer), ITI InnoVec, Strasbourg, France.
[20]
GHRMSA, Mulhouse, France.
[21]
Department of Medical Oncology, University Hospital of Besançon, Besançon, France.;INSERM, EFS BFC, UMR1098, RIGHT, University of Bourgogne Franche-Comté, Besançon, France.;INSERM CIC-1431, Clinical Investigation Center in Biotherapy, University Hospital of Besançon, Besançon, France.
[22]
DOI
10.1200/JCO.22.00096
PMID
36070539
发布时间
2023-02-08
换一批
